Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repair

Published 2015 View Full Article

Authors

Keywords

Journal

OncoTargets and Therapy

Volume -, Issue -, Pages 809

Publisher

Dove Medical Press Ltd.

Online

2015-04-14

DOI

10.2147/ott.s77283

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

OncoTargets and Therapy

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.